China, Intellectual property, IP, Patents, pharma in China
0 Comment
China has become more accepting of Western medicines and sees the value of a strong patenting process, opening the door for more foreign trade and mutual benefits.
generics, Intellectual property, IP, Law, Legal, Patents
0 Comment
IP management can protect pharma companies’ investments and future R&D.
Abbreviated New Drug Applications, ANDA, generics, Intellectual property, IP, litigation, Patents
0 Comment
Sheila Swaroop and Kaitlin Heinen examine the findings of a recent report.
